InsidersTradesSigma
휴마시스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 휴마시스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 휴마시스 has recorded 48 insider filings. Market capitalisation: €45.8bn. The latest transaction was filed on 10 July 2026 (Other). Among the most active insiders: 아티스트. All data is openly available.
47
Insider Decl.
n/a
Thresholds
€3m
14 ops.
Buy Volume
n/a
7 ops.
Sell Volume
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,621 of 28,065 companies
30.1
score / 100
Value50
Quality10
FCF yld19%
Earn yld-30%
EV/EBITDA·
ROE-6.5%
Gross mgn7.4%
Net mgn-52%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 July 2026
Declarations48 total
Other
Other(filed)
25 of 48 declarations
About 휴마시스
Humasis is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of medical diagnostics and innovative health solutions.